Search - tctmd.com

Displaying 81 - 100 of 339

Sort: Relevancy | Date

Presentation TCT 2019

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Presenter: Davide Capodanno

September 28, 2019

Presentation TCT 2019

Potential of NaF PET Imaging for Vulnerable Plaque and Patient Identification

Presenter: Bon-Kwon Koo

September 27, 2019

Presentation TCT 2019

Integration of Non-Invasive and Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Presenter: Ryan Madder

September 27, 2019

Presentation TCT 2019

Non-Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Presenter: James Min

September 27, 2019

Presentation TCT 2019

Utility of OCT-NIRF Molecular Imaging for Vulnerable Plaque Identification

Presenter: Farouc Jaffer

September 27, 2019

Presentation TCT 2019

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Presenter: Peter Stone

September 27, 2019

Presentation TCT 2019

Treatment of Vulnerable Patients and Plaques: PREVENT Rationale and Update

Presenter: Seung-Jung Park

September 27, 2019

Presentation TCT 2019

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

Presenter: David Erlinge

September 27, 2019

Presentation TCT 2019

Updated Results and Implications of the Lipid-Rich Plaque Study of NIR Spectroscopy

Presenter: Ron Waksman

September 27, 2019

Presentation TCT 2019

IVUS and OCT Imaging for the Detection of Vulnerable Plaque and Patients

Presenter: Francesco Prati

September 27, 2019

Presentation TCT 2019

Perivascular Sirolimus for Prevention of Dialysis Access Failure: Sirogen Technology Overview and Early Human Experience

Presenter: Sriram Iyer

September 27, 2019

Presentation TCT 2019

Unexpected Shock: Where Does It Come From?

Presenter: Merida Cardenas Manilla

September 27, 2019

Presentation TCT 2019

Unusual Situation During Transradial Intervention

Presenter: Purich Surunchuakorn

September 27, 2019

Presentation TCT 2019

No Reflow After Balloon Angioplasty

Presenter: Cheng Han Lee

September 27, 2019

Presentation TCT 2019

'Til Death Do Us Tear Apart

Presenter: Aaron Wong Sung Lung

September 27, 2019

Presentation TCT 2019

Introduction

Presenter: Michael Haude

September 27, 2019

Presentation TCT 2019

What is a High Risk PFO, and Should it Affect the Decision to Close?

Presenter: Jonathan Tobis

September 27, 2019

Presentation TCT 2019

Who Should Perform PFO Closure, and Where? The SCAI Expert Consensus Statement

Presenter: Clifford Kavinsky

September 27, 2019

Presentation TCT 2019

PFO in 2019, A Neurologist’s Perspective

Presenter: David Thaler

September 27, 2019

Presentation TCT 2019

The Heart-Brain Team: PFO Closure Should Require the Approval of a Neurologist

Presenter: Andrew Goldsweig, MD

September 27, 2019

Advertisement

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Potential of NaF PET Imaging for Vulnerable Plaque and Patient Identification

Integration of Non-Invasive and Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Non-Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Utility of OCT-NIRF Molecular Imaging for Vulnerable Plaque Identification

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Treatment of Vulnerable Patients and Plaques: PREVENT Rationale and Update

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

Updated Results and Implications of the Lipid-Rich Plaque Study of NIR Spectroscopy

IVUS and OCT Imaging for the Detection of Vulnerable Plaque and Patients

Perivascular Sirolimus for Prevention of Dialysis Access Failure: Sirogen Technology Overview and Early Human Experience

Unexpected Shock: Where Does It Come From?

Unusual Situation During Transradial Intervention

No Reflow After Balloon Angioplasty

'Til Death Do Us Tear Apart

Introduction

What is a High Risk PFO, and Should it Affect the Decision to Close?

Who Should Perform PFO Closure, and Where? The SCAI Expert Consensus Statement

PFO in 2019, A Neurologist’s Perspective

The Heart-Brain Team: PFO Closure Should Require the Approval of a Neurologist

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content